Replies to post #439810 on Amarin Corp Plc (AMRN)

[rosemountbomber]

That is correct JRoon. Of all the things that could happen, any money transferring from Hikma to Amarin would be the absolute last to occur.

[TastyTheElf]

You might be right. But Hikma stopping selling Vascepa now would be rearranging deck chairs on the Titanic. If you can limit damages to $5bn instead of $5.2bn when $2bn will bankrupt you, what's the difference?

Hikma may be able to drag this out in appeals, but if a pending judgment hits their balance sheet, they are out of business. No one will bank them. See Pennzoil vs Texaco.

[Birdbrain Ideas]

It is true that nobody knows what will happen with the Hikma lawsuit, but I do know for certainty that nothing in this case can shut down all the generics, which is what you suggested was a possibility. This case is specific to Hikma. If the other generics had similarly broken the rules, those generics would have been added as defendants to the lawsuit. They were not. So they have nothing to fear. Now that 2006 is around the corner, it's interesting that we'll only be three years away from what would have been the expiration of the patents anyway. If the generics had waited, Amarin would have advertised Vascepa heavily and grown the market so that generics would be eating a slice of a $2 billion cake. Instead, the piggy vulture generics will be nibbling on the crumbs of the marketplace they destroyed. I still don't get their reasoning.